Organon Quick Ratio 2019-2025 | OGN
Historical quick ratio values for Organon (OGN) over the last 10 years.
| Organon Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2025-03-31 | $3.01B | $2.62B | 1.15 |
| 2024-12-31 | $3.03B | $2.72B | 1.11 |
| 2024-09-30 | $3.37B | $2.79B | 1.21 |
| 2024-06-30 | $3.22B | $2.76B | 1.17 |
| 2024-03-31 | $2.93B | $2.55B | 1.15 |
| 2023-12-31 | $3.19B | $2.92B | 1.09 |
| 2023-09-30 | $2.86B | $2.49B | 1.15 |
| 2023-06-30 | $2.76B | $2.39B | 1.16 |
| 2023-03-31 | $2.66B | $2.35B | 1.13 |
| 2022-12-31 | $2.93B | $2.51B | 1.17 |
| 2022-09-30 | $2.71B | $2.33B | 1.17 |
| 2022-06-30 | $2.82B | $2.40B | 1.18 |
| 2022-03-31 | $2.77B | $2.31B | 1.20 |
| 2021-12-31 | $2.85B | $2.60B | 1.10 |
| 2021-09-30 | $3.41B | $3.13B | 1.09 |
| 2021-06-30 | $3.04B | $2.98B | 1.02 |
| 2021-03-31 | $2.05B | $2.88B | 0.71 |
| 2020-12-31 | $2.65B | $2.67B | 0.99 |
| 2020-09-30 | $0.00B | 0.00 | |
| 2020-06-30 | $0.00B | 0.00 | |
| 2020-03-31 | $0.00B | 0.00 | |
| 2019-12-31 | $2.88B | $1.34B | 2.15 |
| 2018-12-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.636B | $6.403B |
| Organon is a healthcare company. It focuses on the health of women throughout their lives. Organon is based in JERSEY CITY, N.J. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.115B | 27.47 |
| CVS Health (CVS) | United States | $75.901B | 9.43 |
| Elevance Health (ELV) | United States | $65.016B | 8.74 |
| Cencora (COR) | United States | $56.164B | 19.54 |
| DiDi Global (DIDIY) | China | $25.650B | 27.25 |
| Labcorp Holdings (LH) | United States | $21.906B | 17.29 |
| Natera (NTRA) | United States | $18.548B | 0.00 |
| BioMerieux (BMXMF) | France | $17.068B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.156B | 0.00 |
| ICON (ICLR) | Ireland | $14.957B | 14.39 |
| CochLear (CHEOY) | Australia | $13.609B | 0.00 |
| Solventum (SOLV) | United States | $12.725B | 13.47 |
| Medpace Holdings (MEDP) | United States | $12.583B | 33.30 |
| Revvity (RVTY) | United States | $11.135B | 19.32 |
| Viatris (VTRS) | United States | $10.786B | 3.71 |
| Avantor (AVTR) | United States | $9.547B | 13.87 |
| Sonic Healthcare (SKHHY) | Australia | $9.074B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.765B | 17.17 |
| HealthEquity (HQY) | United States | $8.282B | 36.28 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.001B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $5.183B | 30.52 |
| Amplifon S.p.A (AMFPF) | Italy | $5.058B | 27.69 |
| BrightSpring Health Services (BTSG) | United States | $3.534B | 32.42 |
| Sotera Health (SHC) | United States | $3.446B | 19.58 |
| Surgery Partners (SGRY) | United States | $2.862B | 37.22 |
| GeneDx Holdings (WGS) | United States | $2.619B | 60.38 |
| Concentras Parent (CON) | United States | $2.589B | 14.96 |
| Alignment Healthcare (ALHC) | United States | $2.331B | 0.00 |
| Progyny (PGNY) | United States | $1.957B | 43.08 |
| PACS (PACS) | United States | $1.757B | 0.00 |
| Premier (PINC) | United States | $1.749B | 13.27 |
| GoodRx Holdings (GDRX) | United States | $1.739B | 34.79 |
| Ardent Health (ARDT) | United States | $1.532B | 6.53 |
| Teladoc Health (TDOC) | United States | $1.321B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.192B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.088B | 8.28 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.875B | 300.00 |
| Agilon Health (AGL) | United States | $0.799B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.740B | 6.93 |
| CareDx (CDNA) | United States | $0.708B | 11.06 |
| Embecta (EMBC) | United States | $0.628B | 4.23 |
| So-Young (SY) | China | $0.507B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.489B | 0.00 |
| Nutex Health (NUTX) | United States | $0.474B | 7.18 |
| Sonida Senior Living (SNDA) | United States | $0.469B | 0.00 |
| Omada Health (OMDA) | $0.468B | 0.00 | |
| LifeMD (LFMD) | United States | $0.464B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.456B | 10.27 |
| SBC Medicals (SBC) | United States | $0.454B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.401B | 0.00 |
| Enhabit (EHAB) | United States | $0.337B | 27.75 |
| Oncology Institute (TOI) | United States | $0.323B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.276B | 0.00 |
| Beauty Health (SKIN) | United States | $0.213B | 0.00 |
| DocGo (DCGO) | United States | $0.145B | 23.67 |
| Sera Prognostics (SERA) | United States | $0.109B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| KindlyMD (NAKA) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Biodesix (BDSX) | United States | $0.057B | 0.00 |
| ModivCare (MODV) | United States | $0.043B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.042B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.040B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |